Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL

por Tian, Ze, Shi, Chunhua, Yang, Guojun, Allen, Jason K., Shi, Qing, AL-Shami, Amin, Olson, Jill Wardell, Smith, Melinda G., Chang, Qing, Kaur, Jasbir, You, Junping, Lofton, Timothy E., Gonzalez, Michelle A., Zhang, Qi, Zha, DongXing, Tasian, Sarah K., Jain, Nitin, Konopleva, Marina Y., Heffernan, Timothy, Molldrem, Jeffrey J.
Publicado 2023